BioHorizons hold approximately 10% of the global market Merchantech in a market that most analysts are forecasting to grow by around 10% per annum in the next decade. The marketing value for CelGro technology in this deal grossly under reflected in this share price. Just a waiting game as the revenues begin to come in, or buying opportunity for those with cash and the knowledge of this stock. We all know dental just a small aspect of the potential and this will establish a credible base for nerve and tendon commercialisation potential.
Still not up on BH' website as yet, but soon to come:
https://www.biohorizons.com/products/Membranes
Nice to see news in OCC making some of the larger US investment websites that recycle news from an investment perspective:
https://www.marketscreener.com/quote/stock/ORTHOCELL-LIMITED-16699926/news/Orthocell-Receives-First-Orders-for-Collagen-Medical-Devices-Striate-Remplir-Shares-Jump-5-41864838/
BioHorizons hold approximately 10% of the global market...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.010(2.63%) |
Mkt cap ! $81.63M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 39.0¢ | $4.163K | 10.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 61416 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 25491 | 3 |
View Market Depth
| Last trade - 11.25am 31/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |